Seres Therapeutics
NASDAQ: MCRB
Healthcare
Biotechnology
Rank
#27180
Market Cap
61.51 M
Volume
131,038
Price
7.06
Change (%)
1.36%
Country or region
United States
United States
Seres Therapeutics's latest marketcap:
61.51 M
As of May 11, 2025, Seres Therapeutics's market capitalization has reached $61.51 M. According to our data, Seres Therapeutics is the 27180th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 61.51 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 72.95 M |
| Shares Out | 8.72 M |
| EPS (ttm) | 0.03 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 7, 2025 |
Market Cap Chart
Data Updated: May 11, 2025
Seres Therapeutics's yearly market capitalization.
Seres Therapeutics has seen its market value drop from $1.37 B to $61.51 M since 2015, representing a total decrease of 95.51% and an annual compound decline rate (CAGR) of 28.22%.
| Date | Market Cap | Change (%) |
|---|---|---|
| May 11, 2025 | $61.51 M | -40.8% |
| December 31, 2024 | $141.90 M | -21.6% |
| December 29, 2023 | $181 M | -74.06% |
| December 30, 2022 | $697.70 M | -8.81% |
| December 31, 2021 | $765.10 M | -65.78% |
| December 31, 2020 | $2.24 B | 825.71% |
| December 31, 2019 | $241.50 M | 30.75% |
| December 31, 2018 | $184.70 M | -55.06% |
| December 29, 2017 | $411 M | 2.88% |
| December 30, 2016 | $399.50 M | -70.85% |
| December 31, 2015 | $1.37 B |
Company Profile
Frequently Asked Questions
As of May 11, 2025, Seres Therapeutics (including the parent company, if applicable) has an estimated market capitalization of $61.51 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Seres Therapeutics global market capitalization ranking is approximately 27180 as of May 11, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2010 |
| IPO Date | June 26, 2015 |
| Employees | 103 |
| CEO | |
| Sector | Healthcare |
| Industry | Biotechnology |
| Address |
